Top

Clinical Orthopaedics and Related Research®

Published in:

01-04-2014 | Clinical Research

Obesity Increases Length of Stay and Direct Medical Costs in Total Hip Arthroplasty

Authors: Hilal Maradit Kremers, MD, MSc, Sue L. Visscher, PhD, Walter K. Kremers, PhD, James M. Naessens, PhD, David G. Lewallen, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 4/2014

Abstract

Background

The number of obese patients undergoing THA is increasing. Previous studies have shown that obesity is associated with an increased likelihood of complications after THA, but there is little information regarding the impact of obesity on medical resource use and direct medical costs in THA.

Questions/purposes

We sought to examine the relationship between obesity, length of stay, and direct medical costs in a large cohort of patients undergoing THAs.

Methods

The study included 8973 patients who had undergone 6410 primary and 2563 revision THAs at a large US medical center between January 1, 2000, and September 31, 2008. Patients with bilateral procedures within 90 days after index admission and patients with acute trauma were excluded. Data regarding clinical, surgical characteristics, and complications were obtained from the original medical records and the institutional joint registry. Patients were classified into eight groups based on their BMI at the time of surgery. Direct medical costs were calculated by using standardized, inflation-adjusted costs for services and procedures billed during hospitalization and the 90-day window. Study end points were hospital length of stay, direct medical costs during hospitalization, and the 90-day window. End points were compared across the eight BMI categories in multivariable risk-adjusted linear regression models.

Results

Mean length of stay and the direct medical costs were lowest for patients with a BMI of 25 to 35 kg/m². Increasing BMI was associated with longer hospital stays and costs. Every five-unit increase in BMI beyond 30 kg/m² was associated with approximately USD $500 higher hospital costs and USD $900 higher 90-day costs in primary THA (p = 0.0001), which corresponded to 5% higher costs. The cost increase associated with BMI was greater in the revision THA cohort where every five-unit increase in BMI beyond 30 kg/m² was associated with approximately USD $800 higher hospital costs and USD $1500 higher 90-day costs. These estimates remained unchanged after adjusting for comorbidities or complications.

Conclusions

Obesity is associated with longer hospital stays and higher costs in THA. The significant effect of obesity on costs persists even among patients without comorbidities but the increased costs associated with obesity may be balanced by the potential benefits of THA in the obese. Increasing prevalence of obesity likely contributes to the increasing financial burden of THA worldwide.

Level of Evidence

Level IV, economic and decision analyses. See the Instructions for Authors for a complete description of levels of evidence.

Andrew JG, Palan J, Kurup HV, Gibson P, Murray DW, Beard DJ. Obesity in total hip replacement. J Bone Joint Surg Br. 2008;90:424–429.PubMedCrossRef

Apold H, Meyer HE, Espehaug B, Nordsletten L, Havelin LI, Flugsrud GB. Weight gain and the risk of total hip replacement: a population-based prospective cohort study of 265,725 individuals. Osteoarthritis Cartilage. 2011;19:809–815.PubMedCrossRef

Arterburn DE, Maciejewski ML, Tsevat J. Impact of morbid obesity on medical expenditures in adults. Int J Obesity. 2005;29:334–339.CrossRef

Batsis JA, Naessens JM, Keegan MT, Wagie AE, Huddleston PM, Huddleston JM. Impact of body mass on hospital resource use in total hip arthroplasty. Public Health Nutr. 2009;12:1122–1132.PubMedCrossRef

Berry DJ, Kessler M, Morrey BF. Maintaining a hip registry for 25 years: Mayo Clinic experience. Clin Orthop Relat Res. 1997;344:61–68.PubMedCrossRef

Centers for Medicare & Medicaid Services. Berenson-Eggers Type of Service (BETOS) codes. 2011. Available at: https://www.cms.gov/HCPCSReleaseCodeSets/20_BETOS.asp. Accessed September 16, 2013.

Davis AM, Wood AM, Keenan ACM, Brenkel IJ, Ballantyne JA. Does body mass index affect clinical outcome post-operatively and at five years after primary unilateral total hip replacement performed for osteoarthritis? A multivariate analysis of prospective data. J Bone Joint Surg Br. 2011;93:1178–1182.PubMedCrossRef

Dominick KL, Dudley TK, Coffman CJ, Bosworth HB. Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Rheum. 2005;53:666–672.PubMedCrossRef

Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.PubMedCrossRef

10.

Epstein AM, Read JL, Hoefer M. The relation of body-weight to length of stay and charges for hospital services for patients undergoing elective surgery: a study of two procedures. Am J Public Health. 1987;77:993–997.PubMedCentralPubMedCrossRef

11.

Fehring TK, Odum SM, Griffin WL, Mason JB, McCoy TH. The obesity epidemic: its effect on total joint arthroplasty. J Arthroplasty. 2007;22(6 suppl 2):71–76.PubMedCrossRef

12.

Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 2009;28:w822–831.PubMedCrossRef

13.

Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307:491–497.PubMedCrossRef

14.

Gonzalez Della Valle A, Chiu YL, Ma Y, Mazumdar M, Memtsoudis SG. The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States. J Arthroplasty. 2012;27:1743–1749.e1.

15.

Hauck K, Hollingsworth B. The impact of severe obesity on hospital length of stay. Med Care. 2010;48:335–340.PubMedCrossRef

16.

Haverkamp D, Klinkenbijl MN, Somford MP, Albers GH, van der Vis HM. Obesity in total hip arthroplasty: does it really matter? A meta-analysis. Acta Orthop. 2011;82:417–422.PubMedCentralPubMedCrossRef

17.

Huddleston JI, Wang Y, Uquillas C, Herndon JH, Maloney WJ. Age and obesity are risk factors for adverse events after total hip arthroplasty. Clin Orthop Relat Res. 2012;470:490–496.PubMedCentralPubMedCrossRef

18.

Jackson MP, Sexton SA, Yeung E, Walter WL, Walter WK, Zicat BA. The effect of obesity on the mid-term survival and clinical outcome of cementless total hip replacement. J Bone Joint Surg Br. 2009;91:1296–1300.PubMedCrossRef

19.

Jibodh SR, Gurkan I, Wenz JF. In-hospital outcome and resource use in hip arthroplasty: influence of body mass. Orthopedics. 2004;27:594–601.PubMed

20.

Jones CA, Cox V, Jhangri GS, Suarez-Almazor ME. Delineating the impact of obesity and its relationship on recovery after total joint arthroplasties. Osteoarthritis Cartilage. 2012;20:511–518.PubMedCrossRef

21.

Kim SH. Morbid obesity and excessive hospital resource consumption for unilateral primary hip and knee arthroplasty. J Arthroplasty. 2010;25:1258–1266.PubMedCrossRef

22.

Kim Y, Morshed S, Joseph T, Bozic K, Ries MD. Clinical impact of obesity on stability following revision total hip arthroplasty. Clin Orthop Relat Res. 2006;453:142–146.PubMedCrossRef

23.

Lowe GD, Haverkate F, Thompson SG, Turner RM, Bertina RM, Turpie AG, Mannucci PM. Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European Concerted Action on Thrombosis. Thromb Haemost. 1999;81:879–886.PubMed

24.

Lubbeke A, Moons KG, Garavaglia G, Hoffmeyer P. Outcomes of obese and nonobese patients undergoing revision total hip arthroplasty. Arthritis Rheum. 2008;59:738–745.PubMedCrossRef

25.

Lubbeke A, Stern R, Garavaglia G, Zurcher L, Hoffmeyer P. Differences in outcomes of obese women and men undergoing primary total hip arthroplasty. Arthritis Rheum. 2007;57:327–334.PubMedCrossRef

26.

Maradit Kremers H, Visscher SL, Moriarty JP, Reinalda MS, Kremers WK, Naessens JM, Lewallen DG. Determinants of direct medical costs in primary and revision total knee arthroplasty. Clin Orthop Relat Res. 2013;471:206–214.PubMedCentralPubMedCrossRef

27.

McCalden RW, Charron KD, MacDonald SJ, Bourne RB, Naudie DD. Does morbid obesity affect the outcome of total hip replacement?: an analysis of 3290 THRs. J Bone Joint Surg Br. 2011;93:321–325.PubMedCrossRef

28.

McLaughlin JR, Lee KR. The outcome of total hip replacement in obese and non-obese patients at 10- to 18-years. J Bone Joint Surg Br. 2006;88:1286–1292.PubMedCrossRef

29.

Mnatzaganian G, Ryan P, Norman PE, Davidson DC, Hiller JE. Use of routine hospital morbidity data together with weight and height of patients to predict in-hospital complications following total joint replacement. BMC Health Serv Res. 2012;12:380.PubMedCentralPubMedCrossRef

30.

Moriarty JP, Branda ME, Olsen KD, Shah ND, Borah BJ, Wagie AE, Egginton JS, Naessens JM. The effects of incremental costs of smoking and obesity on health care costs among adults: a 7-year longitudinal study. J Occup Environ Med. 2012;54:286–291.PubMedCrossRef

31.

Namba RS, Paxton L, Fithian DC, Stone ML. Obesity and perioperative morbidity in total hip and total knee arthroplasty patients. J Arthroplasty. 2005;20(7 suppl 3):46–50.PubMedCrossRef

32.

Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89:33–38.PubMedCrossRef

33.

Perka C, Labs K, Muschik M, Buttgereit F. The influence of obesity on perioperative morbidity and mortality in revision total hip arthroplasty. Arch Orthop Trauma Surg. 2000;120:267–271.PubMedCrossRef

34.

Quesenberry CP Jr, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med. 1998;158:466–472.PubMedCrossRef

35.

Reinke CE, Kelz RR, Zubizarreta JR, Mi L, Saynisch P, Kyle FA, Even-Shoshan O, Fleisher LA, Silber JH. Obesity and readmission in elderly surgical patients. Surgery. 2012;152:355–362.PubMedCentralPubMedCrossRef

36.

Roder C, Bach B, Berry DJ, Eggli S, Langenhahn R, Busato A. Obesity, age, sex, diagnosis, and fixation mode differently affect early cup failure in total hip arthroplasty: a matched case-control study of 4420 patients. J Bone Joint Surg Am. 2010;92:1954–1963.PubMedCrossRef

37.

Sadr Azodi O, Adami J, Lindstrom D, Eriksson KO, Wladis A, Bellocco R. High body mass index is associated with increased risk of implant dislocation following primary total hip replacement: 2,106 patients followed for up to 8 years. Acta Orthop. 2008;79:141–147.PubMedCrossRef

38.

Sadr Azodi O, Bellocco R, Eriksson K, Adami J. The impact of tobacco use and body mass index on the length of stay in hospital and the risk of post-operative complications among patients undergoing total hip replacement. J Bone Joint Surg Br. 2006;88:1316–1320.PubMedCrossRef

39.

Silber JH, Rosenbaum PR, Kelz RR, Reinke CE, Neuman MD, Ross RN, Even-Shoshan O, David G, Saynisch PA, Kyle FA, Bratzler DW, Fleisher LA. Medical and financial risks associated with surgery in the elderly obese. Ann Surg. 2012;256:79–86.PubMedCentralPubMedCrossRef

40.

Stargardt T. Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries. Health Econ. 2008;17(1 suppl):S9–20.PubMedCrossRef

41.

Stevens M, Paans N, Wagenmakers R, van Beveren J, van Raay J, van der Meer K, Stewart R, Bulstra SK, Reininga IH, van den Akker-Scheek I. The influence of overweight/obesity on patient-perceived physical functioning and health-related quality of life after primary total hip arthroplasty. Obes Surg. 2012;22:523–529.PubMedCentralPubMedCrossRef

42.

Tomek IM, Sabel AL, Froimson MI, Muschler G, Jevsevar DS, Koenig KM, Lewallen DG, Naessens JM, Savitz LA, Westrich JL, Weeks WB, Weinstein JN. A collaborative of leading health systems finds wide variations in total knee replacement delivery and takes steps to improve value. Health Aff (Millwood). 2012;31:1329–1338.PubMedCrossRef

43.

Vincent HK, Horodyski M, Gearen P, Vlasak R, Seay AN, Conrad BP, Vincent KR. Obesity and long term functional outcomes following elective total hip replacement. J Orthop Surg Res. 2012;7:16.PubMedCentralPubMedCrossRef

44.

Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Obesity and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378:815–825.PubMedCrossRef

45.

Withrow D, Alter DA. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev. 2011;12:131–141.PubMedCrossRef

46.

Yeung E, Jackson M, Sexton S, Walter W, Zicat B, Walter W. The effect of obesity on the outcome of hip and knee arthroplasty. Int Orthop. 2011;35:929–934.PubMedCentralPubMedCrossRef

47.

Zizza C, Herring AH, Stevens J, Popkin BM. Length of hospital stays among obese individuals. Am J Public Health. 2004;94:1587–1591.PubMedCentralPubMedCrossRef

Title: Obesity Increases Length of Stay and Direct Medical Costs in Total Hip Arthroplasty
Authors: Hilal Maradit Kremers, MD, MSc
Sue L. Visscher, PhD
Walter K. Kremers, PhD
James M. Naessens, PhD
David G. Lewallen, MD
Publication date: 01-04-2014
Publisher: Springer US
Published in: Clinical Orthopaedics and Related Research® / Issue 4/2014
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI: https://doi.org/10.1007/s11999-013-3316-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Obesity Increases Length of Stay and Direct Medical Costs in Total Hip Arthroplasty

Abstract

Background

Questions/purposes

Methods

Results

Conclusions

Level of Evidence

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Questions/purposes

Methods

Results

Conclusions

Level of Evidence

Please log in to get access to this content

Other articles of this Issue 4/2014

CORR Insights®: Risk Factors for Revision Within 10 Years of Total Knee Arthroplasty

Functional Task Kinematics of the Thumb Carpometacarpal Joint

Obituary: A Remembrance of Prof. Ugo del Torto (1923–2011)

Trapeziometacarpal Joint Stability: The Evolving Importance of the Dorsal Ligaments

Subungual Exostosis of the Toes: A Systematic Review

Patients With Hip Osteoarthritis Have a Phenotype With High Bone Mass and Low Lean Body Mass